HilleVax, Inc., (HLVX) Social Stream



HilleVax, Inc., (HLVX): $19.07

0.04 (+0.21%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HLVX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

HILLEVAX INC (HLVX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering HILLEVAX INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-11-14 4 $40 $24 $32 $21.15 51.3%
NA 4 $NA $NA $NA $21.15 NA%

Over the past 174 days, HLVX's average upside potential has been 176.11%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-24 4 40 24 32 10.11 216.52%
2022-06-10 4 40 24 32 9.00 255.56%
2022-08-12 4 40 24 32 12.06 165.34%
2022-11-14 4 40 24 32 19.16 67.01%

HLVX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • HILLEVAX INC's number of analysts covering the stock is higher than 33.84% of all US stocks.
  • HILLEVAX INC's average analyst price target is greater than 75.22% of stocks in the small market cap category.
  • In the context of Pharmaceutical Products stocks, HILLEVAX INC's upside potential (average analyst target price relative to current price) is greater than 24.97% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, HILLEVAX INC's variance in analysts' estimates is lower than 64.06% of them.

Stocks similar to HILLEVAX INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PRME, CDXC, and MTEX.

What is the outlook for HLVX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6648 seconds.